However, therapy with LC has proven to be beneficial for the control of diabetes, insulin resistance, high blood pressure, and dyslipidaemia in prior investigations (Zhang et al., 2014)
This streamlined model eliminates the barriersinsurance denials, long appointment waits, pharmacy transfersthat often prevent people from accessing GLP-1 therapy
The outcomes of the STEP studies were impressive: Wegovy should be used for the chronic management of obesity or overweight with an existing weight-related medical problem such as diabetes, hypertension or sleep apnea
Instead of following a rigid sequence, clinicians now adopt a more flexible and patient-centered approach
When combined with intensive behavioral therapy and a low-calorie diet, it can result in greater weight loss
Visible inch loss: Watching measurements decrease and clothes fit better creates genuine excitement and motivation to continue